RNF182 and Alzheimer disease: Evidence of upregulation of Rnf182 in the brain of AD patients suggests that Rnf182 is involved in the pathophysiological process of AD via induced degradation of ATP6V0C, a key component of the gap junction and neurotransmitter release pathway in the brain.61